2020
DOI: 10.3233/jrs-191033
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical cost analysis of dental diseases: An Indian scenario

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…Ibuprofen was more affordable as the most expensive brand costs Rs.1.6 per unit, which was similar to a previous study with a cost of Rs. 2.95 per unit [15].…”
Section: Discussionmentioning
confidence: 97%
“…Ibuprofen was more affordable as the most expensive brand costs Rs.1.6 per unit, which was similar to a previous study with a cost of Rs. 2.95 per unit [15].…”
Section: Discussionmentioning
confidence: 97%
“…We used PharmaTrac, a national-level private-sector drug sales audit dataset created by the All-Indian Origin Chemists and Distributors Ltd. (AIOCD Ltd.), used by government agencies for policy decisions, including price regulation, and by researchers. 13 , 14 , 17 , 18 , 19 …”
Section: Methodsmentioning
confidence: 99%